Venture Capital

Retail's next frontier is here. AI agents are moving beyond chatbots to autonomously discover, select, and purchase goods on your behalf. Here's what's coming.

With a massive $200M Series C, Soley Therapeutics is using its AI cell-sensing platform to fast-track novel cancer drugs from code to clinic.

With its revolutionary Prime Editing tech showing promise, Prime Medicine faces a pivotal moment at the J.P. Morgan conference. Can it justify its new strategy?

A new Deloitte study shows EV interest stalling as affordability woes and practical concerns push buyers back to gas and hybrids, rocking brand loyalty.

Kelonia Therapeutics gets the FDA green light to expand trials for its in vivo CAR-T therapy, a single-infusion treatment that could redefine cancer care.

As its SPAC merger with Churchill Capital IX nears, PlusAI will meet investors at a key conference, showcasing its autonomous trucking tech and strategy.

A federal grant for a Quebec mine signals Canada's strategic move to build a domestic LFP battery supply chain and challenge China's market dominance.

Anterix hires a new product chief and sees its COO depart, signaling a major pivot from spectrum provider to a full-service solutions leader for utilities.

With positive Phase 2 results for its antibody AP-101, AL-S Pharma targets a key protein in both genetic and sporadic forms of ALS, offering new hope.

The MTA's major investment in Wabtec's hybrid locomotives promises cleaner air for New York, safer work for crews, and a more reliable subway system.

China's EngineAI unveils its powerful T800 humanoid at CES 2026, backed by massive funding and signaling a new era in the global robotics race.

Following record financial growth, RadNet promotes four executives to accelerate its shift toward proactive, AI-driven healthcare and expand its market dominance.

With new CEO Guillaume Bacuvier, process intelligence leader ARIS is betting its future on becoming the essential governance platform for Agentic AI.

A new multi-target deal combines cutting-edge platforms to create next-gen cancer drugs, aiming to improve precision and patient outcomes.

A new alliance pairs Relation's 'Lab-in-the-Loop' AI with Deerfield's investment might, aiming to fast-track novel drugs for intractable diseases.

With seasoned executive Adam Rosenberg at the helm, AstronauTx is advancing its novel sleep-focused therapy, backed by major investors, into the Alzheimer's arena.

At CES 2026, a powerful innovation engine called XbotPark & InnoX is showcasing over 40 AI hardware startups, revealing a new model for building tech giants.

Startup Guangfan Technology debuts vision-enabled AI earbuds at CES, promising a proactive assistant that sees your world. But is society ready for it?

As COO/CFO Ashim Gupta prepares for a key investor conference, UiPath aims to prove its 'agentic automation' strategy can deliver sustained growth.

With a $30.9M rights offering, Rare Element Resources aims to advance its Wyoming project, a key piece in America's race for rare earth independence.